glp 1 drugs and breastfeeding GLP-1 Breastfeeding: Safety Evidence and Clinical Consider... – PlexusDx Postpartum weight loss is one

There is no specific antidote

Tirzepatides boxed warning and labeled warnings exist because it completed the review that produces such labeling

doi: 10.3389/fcvm.2025.1545231 Received 14 December 2024 Accepted 31 March 2025 Published 16 April 2025 Volume 12 - 2025 Edited by Xintian Cai, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, China Reviewed by Qiyao Xu, Nanjing University of Chinese Medicine, China Di Shen, People's Hospital of Xinjiang Uygur Autonomous Region, China Updates Copyright 2025 Liu, Yu, Lu, Liu, Chen and Li

The peptide was originally characterized by the Sikiric group at the University of Zagreb School of Medicine and has been investigated for over two decades in preclinical research models for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular tissues